Q4 2024. Management View. CEO Magnus Ahlqvist highlighted 4% organic sales growth and a 7.3% operating margin for the quarter. T ...

Merck reported Q4 sales of $15.62 billion, surpassing estimates, with EPS at $1.72. Goldman Sachs remains bullish despite a ...

Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of ...

Analyst Daina Graybosch of Leerink Partners maintained a Buy rating on Merck & Company (MRK – Research Report), reducing the price target to $119.00. Discover outperforming stocks and invest ...

JPM25 is in full swing as several pharma powerhouses—including Merck, Lilly and Amgen—detail their strategies for growth in the coming year. After an explosive opening marked by a suite of ...

In separate presentations, the CEOs of Bristol Myers Squibb, Pfizer and Merck laid out their plans to overcome high-profile losses of exclusivity (LOEs) slated to dent sales through the end of the ...

Merck & Co. expects to launch an easier-to-administer version of its blockbuster cancer treatment Keytruda before the end of the year, accelerating the company’s efforts to protect its top ...

Executives at Amgen made the case for MariTide’s differentiation, while Merck’s CEO contended that Keytruda’s ... At a discussion with reporters Tuesday, a group of Amgen executives defended ...

including Merck, which is engaged in a multi-trial collaboration with N-Power. N-Power can now provide significantly greater access to a more representative group of geographically diverse ...

Smartphone batteries typically show more noticeable signs of wear after 1.5 to 2 years of daily use. However, experts say you can extend your battery’s overall lifespan by making smart choices when ...